Cargando…
Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges
Dementia with Lewy bodies (DLB) is one of the most common causes of dementia and belongs to the group of α-synucleinopathies. Due to its clinical overlap with other neurodegenerative disorders and its high clinical heterogeneity, the clinical differential diagnosis of DLB from other similar disorder...
Autores principales: | Combi, Romina, Salsone, Maria, Villa, Chiara, Ferini-Strambi, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069386/ https://www.ncbi.nlm.nih.gov/pubmed/33921279 http://dx.doi.org/10.3390/ijms22083960 |
Ejemplares similares
-
Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021) -
Cognitive profile in prodromal dementia with Lewy bodies
por: Kemp, Jennifer, et al.
Publicado: (2017) -
Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
por: King, Eleanor, et al.
Publicado: (2018) -
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020) -
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
por: Ferini-Strambi, Luigi, et al.
Publicado: (2020)